A month after Amgen gave up on rocatinlimab — which was once seen as a threat to Dupixent — new findings have linked the drug ...

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Kaposi's Sarcoma Market - A Global and Regional Analysis: Focus on Type, Treatment Type, and Region, 2025-2035" has been added to ...

Kyowa Kirin announced it is discontinuing all ongoing clinical trials for rocatinlimab, an investigational anti-OX40 monoclonal antibody, after a safety review identified “emerging concerns” of ...

A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked to immune function, your treatment will likely involve a collaborative ...

Dirk Dittmer, PhD, and colleagues have developed a model of Kaposi sarcoma could be key to the development of new drugs to treat the disease. Kaposi sarcoma is the most common cancer in people living ...

Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat ...

Although antiretroviral therapy has markedly improved survival in people with AIDS-associated Kaposi sarcoma (a type of cancer caused by a virus), the condition is still a life-threatening problem in ...

A study has identified a binding protein in cancer cell's nucleus, known as CHD4, as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune ...

Researchers have developed a model of Kaposi sarcoma that could expedite the development of new drugs to treat the disease, which is the most common cancer in people living with HIV. Researchers at ...